Evaluation of Regional Anticoagulation With Citrate in Extended Hemodialysis

NCT04297839 · clinicaltrials.gov ↗

PHASE3

Phase

SUSPENDED

Status

200

Enrollment

OTHER

Sponsor class

Stopped DUE TO CORONAVIRUS DISEASE, ACTIVITIES INTHE HOSPITAL ARE SUPRESSED

Conditions

Hemodialysis Complication
Acute Kidney Injury
Anticoagulant Toxicity

Interventions

DRUG: Citrate Anticoagulation Solution
DRUG: Control Group (heparin or continuous saline)

Sponsor

University of Sao Paulo General Hospital

Collaborators

[object Object]
[object Object]